language-icon Old Web
English
Sign In
Acemap > Paper > 568PA phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy

568PA phase II study of pemetrexed and erlotinib for metastatic colorectal cancer refractory to standard chemotherapy

2018 
Keywords:
    • Correction
    • Source
    • Cite
    • Save
    • Machine Reading By IdeaReader
    0
    References
    1
    Citations
    NaN
    KQI
    []
    logo
    • CCF Conference Analysis
    • Map Galaxy
    • What's New
    © Copyright 2015-2020 Acemap, Inc. Shanghai Jiao Tong University.